Corrigendum to ‘Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells’[Redox Biol 6(2015):174–182]

Autor: Rodríguez-Hernández, A., Navarro-Villarán, E., González, R., Pereira, S., Soriano-De Castro, L.B., Sarrias-Giménez, A., Barrera-Pulido, L., Álamo-Martínez, J.M., Serrablo-Requejo, A., Blanco-Fernández, G., Nogales-Muñoz, A., Gila-Bohórquez, A., Pacheco, D., Torres-Nieto, M.A., Serrano-Díaz-Canedo, J., Suárez-Artacho, G., Bernal-Bellido, C., Marín-Gómez, L.M., Barcena, J.A., Gómez-Bravo, M.A., Padilla, C.A., Padillo, F.J., Muntané, J.

Publikováno v: In Redox Biology July 2023 63

Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications

Autor: Barrera-Pulido, L., Álamo-Martínez, J.M., Marín-Gómez, L.M., Suárez-Artacho, G., Bernal-Bellido, C., Domínguez-Usero, D., Tallón-Aguilar, L., Pareja-Ciuró, F., Sousa-Martín, J.M., García-González, I., Gómez-Bravo, M.A.

Publikováno v: In Transplantation Proceedings 2009 41(6):2192-2194

Efficacy and Safety of Mycophenolate Mofetil Monotherapy in Liver Transplant Patients With Renal Failure Induced by Calcineurin Inhibitors

Autor: Barrera Pulido, L., Álamo Martínez, J.M., Pareja Ciuró, F., Gómez Bravo, M.A., Serrano Díez-Canedo, J., Bernal Bellido, C., Suárez Artacho, G., García González, I., Pascasio Acevedo, J.M., Bernardos Rodríguez, A.

Publikováno v: In Transplantation Proceedings 2008 40(9):2985-2987

Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

Autor: Vera R, Gonzalez-Flores E, Rubio C, Urbano J, Camps M, Ciampi-Dopazo J, Rincon J, Macias V, Braco M, Suarez-Artacho G

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname

Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::980a2956dd9334fc760e62ab1f973442
https://fundanet.fhpcs.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1299

Efficacy and safety of pancreatic resection techniques

Autor: Pueyo Périz, E., Marín Gómez, L.M., Gómez Dueñas, G., Cepeda Franco, C., Suárez Artacho, G., Álamo Martínez, J.M., Bernal Bellido, C., Padillo Ruiz, F.J., Gómez Bravo, M.Á.

Publikováno v: In Pancreatology April 2022 22(3):e4-e4